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Intrarenal angiotensin (A,,) infusion results in a poorly sustained renal vasoconstrictor
response. To examine the relationship between fade and renal tachyphylaxis to A,,, sub-pressor
doses ofA11 and norepinephrine (NE) were injected into the renal arteries of anesthetized dogs,
resulting in a transient reduction (>50 percent) in renal blood flow. Continuous intrarenal All
infusion, sufficient to reduce renal blood flow by 50 percent, followed. Within five minutes,
despite continued A11 infusion, substantial recovery (73 ± 11 percent) of renal blood flow
occurred; however, the response toA,, bolus injection was lost, but that to NE was sustained.
A second groupofdogs received indomethacin (5 mg/kg intravenously) 30 minutes prior to the
study; the reduction in renal blood flow was better sustained; however, renal tachyphylaxis was
still evident.
INTRODUCTION
Despiteangiotensin's potentvasoconstrictor properties, a perplexing observation has
been its failure to produce a sustained contractile response in vascular smooth muscle
[1,2]. Two phenomena, fade and tachyphylaxis, have been implicated. Fade has been
described as the diminution of response, despite the continued presence of an agonist
[3]. Loss of response may be due to refractoriness or, in the case of vascular smooth
muscle, to an alteration in excitation-contraction coupling or to the contractile
apparatus itself [4]. In this case the refractory state is generalized, and no agonist
would be expected to induce a response. Tachyphylaxis, or specific desensitization,
involves specific loss ofresponse to an agonist following repeated or prolonged exposure
of an effector system [3]. Loss of contractile response is specific for a single agonist,
and the system is capable ofresponding to alternate agonists.
In this investigation, we have attempted to determine the role of prostaglandins in
the poorly sustained renal vascular contractile response to angiotensin and whether
prostaglandin-mediated alterations in vascular tone can be dissociated from specific
desensitization.
METHODS
Studies were performed in ten mixed-breed dogs of both sexes, weighing 14-28 kg.
The animals were kept on ad libitum diet prior to the investigation. Anesthesia was
induced with intravenous pentobarbital sodium (30 mg/kg) and maintained with
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additional doses (5 mg/kg) as required. Respiration was controlled with a cuffed
endotracheal tube and a respirator pump (Harvard Apparatus).
The left kidney was exposed via a flank incision and an appropriately sized
electromagnetic flow probe placed on a proximal segment ofthe artery. Blood flow was
measured either with a Statham flowmeter (Model M 4001) or a Gould Godard
flowmeter (Model SP 2202) which were calibrated in vivo. Arterial pressure was
measured with a transducer (Statham P 23 D C) from a catheter introduced into the
aorta from the femoral artery. Via the contralateral femoral artery a coaxial catheter
system was introduced and advanced into the left renal artery under fluoroscopic
control; a continuous 0.7 ml/minute infusion of normal saline was maintained with a
Harvard infusion pump to prevent clotting of the catheter system. Infusions of
angiotensin 11 (A,,) into the renal artery were given through the inner lumen, while
bolus injections ofA,, and norepinephrine (NE) were given through the outer lumen.
Pressures and flows were monitored continuously on a pen recorder (Grass Instru-
ments). After blood flow and pressure had stabilized, bolus injections ofangiotensin II
(Hypertension, Ciba) and norepinephrine (Levophed bitartrate, Winthrop) were
injected into the renal artery. For each agent a dose was selected that would produce a
fall in renal blood flow of at least 50 percent but would be without effect on systemic
pressure. A minimum period of five minutes was allowed between doses for recovery.
Ten minutes after the last injection ofeither agent, one of the two following protocols
was performed.
PROTOCOLS
Protocol A
After defining thedose-response forAl1 and NE in fivedogs, a continuous infusion of
A,, into the renal artery was initiated at a dose (3-5 ,ug/minute), previously
demonstrated to have minimal systemic pressor effects, while reducing renal blood
flow by at least 70 percent [5]. After five minutes of continuous A,, infusion, bolus
injections of All and NE were repeated. The infusion was discontinued, and bolus
injections ofAl, and NE repeated.
Protocol B
In a second group offive dogs, an identical protocol was followed, but an intravenous
injection of the cyclo-oxygenase inhibitor indomethacin (5 mg/kg) was given 30
minutes prior to defining the dose-response curves for Al, and NE. Thereafter, a
sequence identical to that in Protocol A was followed. The time interval between
discontinuing the All infusion and full recovery of preinfusion bolus A,1 response was
determined for three of five dogs in each protocol. This interval is referred to as
recovery period (Fig. 2).
ANALYSIS
The transient reductions in renal blood flow induced byA,1 and NE were expressed
as A RBF (ml/minute); A RBF was calculated from the baseline renal blood flow,
immediately prior to the bolus challenge. Mean values have been presented with the
standard error as an index ofdispersion. Statistical significance was assessed by either
the student t-test for paired data where appropriate, or nonparametric methods such as
Wilcoxon's rank sum test (WRST) and Fisher's exact test (FET). The null hypothesis
was rejected when a p value of0.05 or less was attained.
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FIG. 1. Renal vascular responses to All
and NE, prior to (left) and following contin-
uous A,, infusion (right). Note that indo-
methacin pretreatment did not prevent the
striking reduction in the responsiveness toA,,
following the continuous infusion. The
reduction in renal blood flow during continu-
ous infusion ofAll is better sustained in dogs
pretreated with indomethacin.
RESULTS
Protocol A
Continuous infusion ofA,, into the renal artery induced a similar response in each
dog. Within 60 seconds renal blood flow decreased from a baseline of 151 ± 23
ml/minute to 43 ± 22 ml/minute (Fig. 1), a 72 percent reduction (p < .01).
Thereafter, renal blood flow began to return toward baseline, so that after five minutes
of continuous A,, infusion, the reduction was 41 ± 17 ml/minute or a 27 percent
reduction from the baseline renal blood flow. At this time, the vasoconstrictor response
to NE was well sustained, but the response to Al, was either absent or markedly
diminished (Fig. 2).
Protocol B
Pretreatment with indomethacin resulted in a fall in renal blood flow, from 133 ± 19
ml/minute to 110 ± 15 ml/minute. TheAl, infusion induced a reduction in renal blood
flow resembling that in protocol A qualitatively (Table 1), but differing in the
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FIG. 2. Schematic tracing ofthe renal vascular response toAll and NE, prior to and after the development
oftachyphylaxis to A,,. Following five minutes ofcontinuous All infusion, the vascular response to bolus All
was lost, while that to NE was sustained. The time interval between discontinuing the A,, infusion and full
recovery ofthe bolus A,, response is designated the recovery period.
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TABLE 1
Comparison of Control (Protocol A) versus Indomethacin (Protocol B)
Pretreated Dogs
Protocol A Protocol B
Baseline RBF (ml/minute) 151 ± 23 133 ± 19
Post-indomethacin 110 ± 15
Dose 3 ng* 6ng
Pre-infusion vascular response tobolus-A,,
(ml/minute) 63 ± 11 68 ± 9
RBF reduction after five minutes ofAll-in-
fusion (ml/minute) 41 ± 17** 75 ± 6
Vascular response tobolus-All post-infusion
(ml/minute) 3.50 ± 2.1 5.50 ± 3.9
Time for full recovery ofbolus-All response 10 ± 3.6*** 25 ± 1.1
(minutes) (n = 3) (n = 3)
*p < .004
**p < .01
***p < .04
tendency of renal blood flow to return toward baseline. After fine minutes of
continuousA,, infusion, the blood flowreduction was 75 ± 6 ml/minuteor a 69 percent
reduction (p < .01).
DISCUSSION
The term "tachyphylaxis," firstemployed todescribe tolerance to the toxiceffects of
foreign proteins after repeated exposure [6], has come in pharmacology to connote a
specific loss of response, following prolonged exposure of an effector system to an
agonist [7]. In the case ofthe renal blood supply, where angiotensin is thought to be an
important regulatory hormone [8], tachyphylaxis to A,, occurs [9]. In an earlier
investigation, we described the specificity ofrenal vascular tachyphylaxis to angioten-
sin and itsoffset [5]. However, because ofthe important roleofprostaglandins in renal
circulatory homeostasis, and the well-documented effect of A,, in promoting renal
prostaglandin release [10], it is conceivable that enhanced renal prostaglandin
production may have accounted for the observed responses. The results ofthe present
investigation suggest that the recovery phase of renal blood flow and specific
desensitization to A,, can be dissociated. Although pretreatment with indomethacin
attenuated the recovery phase of renal blood flow, it did not prevent specific
desensitization to A,,. Recognizing that a number of interventions employed, e.g.,
anesthesia, surgery, and placement ofcatheters into the renal artery, may affect renal
vascular response to exogenous A,,, we selected doses ofbolusA,,, inducing a transient
50 percent reduction in renal blood flow, to adjust for variability between dogs. Our
results support the results of previous investigations that vascular effects of A,, are
accentuated by cyclo-oxygenase inhibitors [11] and extend these observations by
dissociating tachyphylaxis from prostaglandin-mediated alterations in vascular tone.
Confirmation oftachyphylaxis in our model is evidenced by the sustained response to
NE, while bolus A,,, identical to that inducing a 50 percent reduction in renal blood
flow prior to the A,, infusion, was without effect. Although prostaglandin levels were
not measured nor multiple cyclo-oxygenase inhibitors employed, indomethacin is an
agent widely employed for this purpose [10-13], and it produced the expected
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response, a fall in renal blood flow in the anesthetized animal [14,15]. Despite
cyclo-oxygenase inhibition, a specific loss of response to A,,, similar to that of the
control group, wasdemonstrated. NotunlikeAiken's investigations with isolated celiac
and mesenteric arteries [16], our results indicate that at least two mechanisms
contribute to loss of vascular response to A,,. The first appears to be prostaglandin-
dependent and correlates with the recovery phase of renal blood flow, as described by
previous investigators [3,10]. The second mechanism, specific desensitization, can be
identified following cyclo-oxygenase inhibition in the renal vascular bed.
Following termination oftheangiotensin infusion, in threeoffivedogs in protocols A
and B, the time interval (recovery period) required for return of the vasoconstrictor
response to bolusA,, was determined. Ofinterest is the fact that the recovery period in
the indomethacin group (protocol B) was significantly longer (p < .03). Whether this
observation reflects a change in receptor affinity [17], decreased receptor turnover
[18], altered local angiotensinase activity [19], or evidence that prostaglandins may
contribute to recovery from tachyphylaxis cannot be determined from the present
study. The sustained response to NE during loss and recovery ofthe bolusA,, response
favors a specific event, involving receptor availability or perhaps analogous with beta
adrenergic receptor-agonist interaction [20], uncoupling of the A,, receptor from a
proximate mediator of its effector response. The relatively prolonged recovery times
and the short half-life of A,, suggest that factors other than a decrease in the bio-
phase concentration ofA,, alone may be operating. Future investigations designed to
examine recovery time may prove useful in dissecting the elements responsible for
tachyphylaxis.
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